NCT02966730 2025-05-13
Ibrutinib for Patients With Follicular Lymphoma Without Complete Response to Initial Chemoimmunotherapy
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Terminated
Clinical Trials
3 trialsNCT03295240 2025-05-13
The Study of Bendamustine, Rituximab, Ibrutinib, and Venetoclax in Relapsed, Refractory Mantle Cell Lymphoma
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Completed
NCT03219047 2023-07-27
Patient-Derived Xenografts in Personalizing Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed